A carregar...

Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product

PURPOSE: Filgrastim, a recombinant human granulocyte-colony stimulating factor, is widely used to treat congenital and acquired neutropenia. Following patent expiration of the innovator filgrastim product, biosimilar filgrastim products have been approved in the EU and shown to be comparable with th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharm Res
Main Authors: Halim, Liem Andhyk, Márquez, Maripaz, Maas-Bakker, Roel F., Castañeda-Hernández, Gilberto, Jiskoot, Wim, Schellekens, Huub
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6182392/
https://ncbi.nlm.nih.gov/pubmed/30280277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-018-2491-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!